These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29118091)

  • 21. Tracking 20 years of compound-to-target output from literature and patents.
    Southan C; Varkonyi P; Boppana K; Jagarlapudi SA; Muresan S
    PLoS One; 2013; 8(10):e77142. PubMed ID: 24204758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.
    Wang T; Wu MB; Zhang RH; Chen ZJ; Hua C; Lin JP; Yang LR
    Curr Top Med Chem; 2016; 16(9):901-16. PubMed ID: 26303430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding site detection and druggability prediction of protein targets for structure-based drug design.
    Yuan Y; Pei J; Lai L
    Curr Pharm Des; 2013; 19(12):2326-33. PubMed ID: 23082974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of Microcrystal Electron Diffraction (MicroED).
    Mu X; Gillman C; Nguyen C; Gonen T
    Annu Rev Biochem; 2021 Jun; 90():431-450. PubMed ID: 34153215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rapidly evolving role of cryo-EM in drug design.
    Wigge C; Stefanovic A; Radjainia M
    Drug Discov Today Technol; 2020 Dec; 38():91-102. PubMed ID: 34895645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting thermoTRP ion channels:
    Fernández-Ballester G; Fernández-Carvajal A; Ferrer-Montiel A
    Expert Opin Ther Targets; 2020 Nov; 24(11):1079-1097. PubMed ID: 32972264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational approaches for drug discovery.
    Hung CL; Chen CC
    Drug Dev Res; 2014 Sep; 75(6):412-8. PubMed ID: 25195585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latest trends in structure based drug design with protein targets.
    Bagchi A
    Adv Protein Chem Struct Biol; 2020; 121():1-23. PubMed ID: 32312418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational Strategy Revealing the Structural Determinant of Ligand Selectivity towards Highly Similar Protein Targets.
    Wang H; Gao Y; Wang J; Cheng M
    Curr Drug Targets; 2020; 21(1):76-88. PubMed ID: 31556854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response.
    Wilson DM; Deacon AM; Duncton MAJ; Pellicena P; Georgiadis MM; Yeh AP; Arvai AS; Moiani D; Tainer JA; Das D
    Prog Biophys Mol Biol; 2021 Aug; 163():130-142. PubMed ID: 33115610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current role and evolution of X-ray crystallography in drug discovery and development.
    Bijak V; Szczygiel M; Lenkiewicz J; Gucwa M; Cooper DR; Murzyn K; Minor W
    Expert Opin Drug Discov; 2023; 18(11):1221-1230. PubMed ID: 37592849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein X-ray Crystallography and Drug Discovery.
    Maveyraud L; Mourey L
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
    Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-protein interaction inhibitors: advances in anticancer drug design.
    Ferreira LG; Oliva G; Andricopulo AD
    Expert Opin Drug Discov; 2016 Oct; 11(10):957-68. PubMed ID: 27554357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of ribosomal crystal structures in antibiotic drug design.
    Wimberly BT
    Curr Opin Investig Drugs; 2009 Aug; 10(8):750-65. PubMed ID: 19649920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR studies of ligand binding.
    Nitsche C; Otting G
    Curr Opin Struct Biol; 2018 Feb; 48():16-22. PubMed ID: 29017071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.